Earnings Call · Q2 FY2022·2022-08-09

Q2 22EPS -33.93%·Rev n/aQ1 22EPS -100.00%*·Rev n/aQ4 21EPS -100.00%*·Rev n/aQ3 21EPS +100.00%*·Rev n/a⚠ consensus missing

Fortress Biotech, Inc. FBIO

Unidentified Company Representative — Company Representative

Claude Maraoui — Co-Founder President and Chief Executive Officer

Ernest De Paolantonio — Chief Financial Officer

−1.6%1d on move date−3.2% vs SPY3d−4.7%5d−8.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FBIO calls or request research access.

More FBIO calls Browse calls Request research access